BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8245897)

  • 61. Acyclovir treatment for varicella does not lower gpI and IE-62 (p170) antibody responses to varicella-zoster virus in normal children.
    Englund JA; Arvin AM; Balfour HH
    J Clin Microbiol; 1990 Oct; 28(10):2327-30. PubMed ID: 2172288
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Varicella-zoster virus infections in the immunosuppressed child. Treatment with Acyclovir and controls].
    Peyramond D; Denoyel GA; Philip T; Souillet G; Philippe N; Bertrand JL; Bertoye A
    Arch Fr Pediatr; 1983 Feb; 40(2):95-9. PubMed ID: 6347116
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Advances in antiviral therapy: acyclovir.
    Chadwick EG; Shulman ST
    Pediatr Dermatol; 1984 Jul; 2(1):64-70. PubMed ID: 6095238
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cost-consequence models for varicella-zoster virus infections.
    Paul JE; Mauskopf JA; Bell L
    Pharmacotherapy; 1995; 15(5 Pt 2):49S-58S. PubMed ID: 8577631
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Varicella-zoster virus: prospects for control.
    Gershon AA
    Adv Pediatr Infect Dis; 1995; 10():93-124. PubMed ID: 7718215
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Acyclovir therapy of varicella-zoster virus infections in the immunosuppressed children ].
    Peyramond D; Denoyel GA; Bertrand JL; Bertoye A
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):596-602. PubMed ID: 6750532
    [TBL] [Abstract][Full Text] [Related]  

  • 67. One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation.
    Erard V; Guthrie KA; Varley C; Heugel J; Wald A; Flowers ME; Corey L; Boeckh M
    Blood; 2007 Oct; 110(8):3071-7. PubMed ID: 17515400
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Acyclovir treatment prevents varicella-zoster virus replication in PBMC during viremia.
    Wolff MH; Schünemann S
    New Microbiol; 1999 Oct; 22(4):309-14. PubMed ID: 10555200
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Efficacy of Amenamevir for the Treatment of Disseminated Herpes Zoster Complicated with Probable Varicella-zoster Pneumonia in an Immunocompromised Patient.
    Kobayashi H; Yoshida Y; Komoshita T; Suma H; Hosokawa Y; Hirose Y; Sugimoto T; Mokuda S; Hirata S; Sugiyama E
    Intern Med; 2022 Jun; 61(11):1785-1788. PubMed ID: 34776482
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
    Tan HH; Goh CL
    Am J Clin Dermatol; 2006; 7(1):13-29. PubMed ID: 16489840
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular and therapeutic aspects of varicella-zoster virus infection.
    Quinlivan M; Breuer J
    Expert Rev Mol Med; 2005 Aug; 7(15):1-24. PubMed ID: 16098235
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Varicella zoster virus antigens in the epidermis of patients with herpes zoster before and after treatment with acyclovir: an immunohistochemical study.
    Kurokawa I; Yamamoto M; Kurata T
    J Int Med Res; 2001; 29(3):198-203. PubMed ID: 11471857
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Recurrent varicella-zoster infection after acyclovir therapy in immunocompromised patients.
    Oblon DJ; Elfenbein GJ; Rand K; Weiner RS
    South Med J; 1986 Feb; 79(2):256-7. PubMed ID: 3511542
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Acyclovir in the treatment of infection due to herpes viruses.
    Zicha J; Stafová J; Vacek V
    Czech Med; 1986; 9(4):203-5. PubMed ID: 3028734
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Varicella zoster virus: chickenpox and shingles.
    Gould D
    Nurs Stand; 2014 Apr 16-22; 28(33):52-8; quiz 60. PubMed ID: 24734838
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Consequences of varicella-zoster infection: advances in treatment and prevention.
    Olney L; Meissner C
    Clin Dermatol; 1989; 7(1):49-55. PubMed ID: 2647263
    [No Abstract]   [Full Text] [Related]  

  • 77. Clinical Presentation of Herpes Zoster in Immunocompetent and Immunocompromised Hospitalized Children Treated With Acyclovir.
    Kuchar E; Szenborn L; Lis I; Jaroszewska A; Czeladzka J
    J Pediatr Hematol Oncol; 2016 Jul; 38(5):394-7. PubMed ID: 27347778
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Varicella Zoster Virus: A Common Cause of Stroke in Children and Adults.
    Amlie-Lefond C; Gilden D
    J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1561-1569. PubMed ID: 27138380
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS).
    Jacobson MA; Berger TG; Fikrig S; Becherer P; Moohr JW; Stanat SC; Biron KK
    Ann Intern Med; 1990 Feb; 112(3):187-91. PubMed ID: 2297195
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Outbreak of varicella-zoster virus infection among Thai healthcare workers.
    Apisarnthanarak A; Kitphati R; Tawatsupha P; Thongphubeth K; Apisarnthanarak P; Mundy LM
    Infect Control Hosp Epidemiol; 2007 Apr; 28(4):430-4. PubMed ID: 17385149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.